Medtronic prepares to report financial results as analysts revise forecasts
- Analysts forecast Medtronic's quarterly earnings to be $1.23 per share, consistent with the previous year.
- Medtronic anticipates quarterly revenue to reach $8.37 billion, up from $7.92 billion year-over-year.
- The company's upcoming financial results and the positive outlook from analysts indicate a strong market position.
Medtronic plc, headquartered in Galway, Ireland, is set to announce its financial results for the first quarter on August 19, 2025. This announcement will come before the opening bell of the stock market. Analysts anticipate that Medtronic will post quarterly earnings of $1.23 per share, matching the earnings from the previous year. Additionally, the company is projected to report revenue of approximately $8.37 billion, which signifies a notable increase compared to $7.92 billion reported in the same quarter last year. On August 14, Medtronic's board of directors approved a cash dividend of 72 cents per ordinary share for the second quarter. This decision reflects the company's ongoing commitment to shareholder returns amidst a competitive landscape in the medical device sector. Recently, Medtronic shares saw a slight increase of 1.1%, closing at $93.02 on the preceding Friday. Analysts have been revising their forecasts ahead of this earnings call. For instance, JP Morgan analyst Matthew Boss maintained an Overweight rating while increasing the price target from $45 to $46. Goldman Sachs' Brooke Roach also kept a Buy rating and raised the price target from $44 to $45. Other analysts, such as Paul Lejuez from Citigroup, Alex Straton from Morgan Stanley, and Jay Sole from UBS, have similarly adjusted their ratings and price targets, reflecting a bullish sentiment on Medtronic's stock. As the company gears up for the release of its financial results, stakeholders are keenly observing how these figures will impact Medtronic's position in the medical device market. The analysts' ratings and their revisions suggest a confidence in the company's performance and future growth potential.